Rajiha A. Ibrahim, Amete M. Teshal, Surafel F. Dinku, et al.
1
ReAct Action on Antibiotic Resistance
1
Reilly, K.
1
REMM, RITN
1
Republic of Kenya, Ministry of Health
1
Royal Pharmaceutical Society, etal.
1
Sascha Marchang, Natasha Hurley
1
Schieffelin, JS.
1
Seputra, K.P., Tarmono, B.S. Noegroho, et al.,
1
SIGN
1
Springer International Publishing
1
Stop TB Parntership
1
Strengthening Pharmaceutical Systems
1
TB Alliance
1
TB Care II
1
The Dag Hammarskjöld Foundation and ReAct
1
The Ethiopian Public Health Institute
1
the Food and Agriculture Organization of the United Nations (FAO), the World Organisation for Animal Health (OIE) and the World Health Organization (WHO)
1
The International Textbook of Leprosy
1
The Republic of the Union of Myanmar, Ministry of Health, Department of Health, National AIDS Programme
1
The Review on Antimicrobial Resistance
1
The Sentinel Project
1
The World Bank
1
Tilahun Tadesse, B., E. A. Ashley, S. Ongarello et al.
1
UN Environment
1
USAID, Strengthening Pharmaceutical Systems SPS
1
van Ham C., Reilly K., et al.
1
van Ham, C.
1
WHO
1
World Health Organization (Europe)
1
World Health Organization (WHO), Country Office for Myanmar
1
World Health Organization (WHO), Regional Office for the Western Pacific
1
World Health Organization WHO Western-Pacific Region
1
World Health Organization WHO, Food and Agriculture Organization of the United Nations FAO
1
World Health Organization WHO, Regional Office of Europe
1
Wright G.D.
1
Y.-H. Jin
1
Z.-S. Cheng
1
Zerbo P., J. Millogo-Rasolodimby, O. G.Nacoulma-Ouedraogo
1
Васильева Ирина Анатольевна, Самойлова Анастасия Геннадьевна, Эргешов Атаджан Эргешович et al.
1
федеральное государственное бюджетное учреждение центральный научно-исследовательский институт туберкулеза российской академии медицинских наук, Американский международный союз здравоохранения
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
The framework is to be used as a reference guide, applied according to local priorities and needs, and targeted at academic institutions, educators, accreditation bodies, regulatory agencies and other users. The ultimate aim is to ensure that all health workers are equipped with the requisite compet
...
encies at pre-service education and in-service training levels to address AMR in policy and practice settings.
more
This volume introduces Mongolian traditional medicine and details the nature and uses of medicinal plants found in the country.
The book focuses on the medicinal plants used most commonly in Mongolia. Each monograph contains colour pictures of the plant and a wide array of information—from the sc
...
ientific and English names of plants to their microscopic characteristics. While helping record and document traditional medicine practices, the book contributes to the understanding of the value of medicinal plants in Mongolia and increases the evidence base for the safe and efficacious use of herbs in health care.
more
The report reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with such issues as the rise of noncommunicable diseases, leaps in life expectancy, and emergin
...
g threats like climate change and antimicrobial resistance. more
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec
...
tious diseases in the ministries of health (especially but not limited to endemic countries), nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected persons
more
Version 1.1. The WHO protocol has been adapted to resource-limited settings and builds on existing methodologies from the European Centre for Disease Prevention and Control (ECDC), the Global PPS project from University of Antwerp, the US Centers for Disease Control and Prevention (CDC), and the Med
...
icines Utilisation Research in Africa (MURIA).
Point Prevalence Surveys collects information on prescribing practices of antibiotics and other information relevant to treatment and management of infectious diseases in hospitalized patients, and complements surveillance of antimicrobial consumption.
more
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug
...
h conceptually new and
rapid AST technologies have been described, including new phenotyping methods, digital
imaging and genomic approaches, there is no single major, or broadly accepted, technological
breakthrough that leads the field of rapid AST platform development
more
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to
...
see: it is estimated that each year, drug-resistant infections result in at least 25 000 patient deaths and cost the EU EUR 1,5 billion in healthcare costs and through loss of productivity
more